Trials / Completed
CompletedNCT01858636
Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platform (VIP) Vascular Closure Device
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 235 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To characterize the clinical outcomes of Angio-Seal VIP with St. Jude Medical (SJM) collagen through the collection of device/procedure-related major vascular complications and time to hemostasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Angio-Seal VIP 6 French (6F) and 8 French (8F) devices | These devices are used for the vascular closure procedure |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2013-05-21
- Last updated
- 2019-02-05
- Results posted
- 2014-11-18
Locations
6 sites across 2 countries: Germany, Netherlands
Source: ClinicalTrials.gov record NCT01858636. Inclusion in this directory is not an endorsement.